BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 34576039)

  • 1. RNA-Sequencing Based microRNA Expression Signature of Colorectal Cancer: The Impact of Oncogenic Targets Regulated by
    Hozaka Y; Kita Y; Yasudome R; Tanaka T; Wada M; Idichi T; Tanabe K; Asai S; Moriya S; Toda H; Mori S; Kurahara H; Ohtsuka T; Seki N
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular Pathogenesis of Colorectal Cancer: Impact of Oncogenic Targets Regulated by Tumor Suppressive
    Yasudome R; Seki N; Asai S; Goto Y; Kita Y; Hozaka Y; Wada M; Tanabe K; Idichi T; Mori S; Ohtsuka T
    Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36232922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RNA-sequence-based microRNA expression signature in breast cancer: tumor-suppressive miR-101-5p regulates molecular pathogenesis.
    Toda H; Seki N; Kurozumi S; Shinden Y; Yamada Y; Nohata N; Moriya S; Idichi T; Maemura K; Fujii T; Horiguchi J; Kijima Y; Natsugoe S
    Mol Oncol; 2020 Feb; 14(2):426-446. PubMed ID: 31755218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RNA sequencing-based microRNA expression signature in esophageal squamous cell carcinoma: oncogenic targets by antitumor miR-143-5p and miR-143-3p regulation.
    Wada M; Goto Y; Tanaka T; Okada R; Moriya S; Idichi T; Noda M; Sasaki K; Kita Y; Kurahara H; Maemura K; Natsugoe S; Seki N
    J Hum Genet; 2020 Nov; 65(11):1019-1034. PubMed ID: 32623445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA signature of small-cell lung cancer after treatment failure: impact on oncogenic targets by miR-30a-3p control.
    Tanigawa K; Misono S; Mizuno K; Asai S; Suetsugu T; Uchida A; Kawano M; Inoue H; Seki N
    Mol Oncol; 2023 Feb; 17(2):328-343. PubMed ID: 36345848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of UHRF1 by dual-strand tumor-suppressor microRNA-145 (miR-145-5p and miR-145-3p): Inhibition of bladder cancer cell aggressiveness.
    Matsushita R; Yoshino H; Enokida H; Goto Y; Miyamoto K; Yonemori M; Inoguchi S; Nakagawa M; Seki N
    Oncotarget; 2016 May; 7(19):28460-87. PubMed ID: 27072587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Oncogenic Targets by Tumor-Suppressive
    Koma A; Asai S; Minemura C; Oshima S; Kinoshita T; Kikkawa N; Koshizuka K; Moriya S; Kasamatsu A; Hanazawa T; Uzawa K; Seki N
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deep sequencing-based microRNA expression signatures in head and neck squamous cell carcinoma: dual strands of pre-miR-150 as antitumor miRNAs.
    Koshizuka K; Nohata N; Hanazawa T; Kikkawa N; Arai T; Okato A; Fukumoto I; Katada K; Okamoto Y; Seki N
    Oncotarget; 2017 May; 8(18):30288-30304. PubMed ID: 28415821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of miR-30a-3p Regulation of Oncogenic Targets in Pancreatic Ductal Adenocarcinoma Pathogenesis.
    Shimomura H; Okada R; Tanaka T; Hozaka Y; Wada M; Moriya S; Idichi T; Kita Y; Kurahara H; Ohtsuka T; Seki N
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32899691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual strands of the miR-223 duplex (miR-223-5p and miR-223-3p) inhibit cancer cell aggressiveness: targeted genes are involved in bladder cancer pathogenesis.
    Sugawara S; Yamada Y; Arai T; Okato A; Idichi T; Kato M; Koshizuka K; Ichikawa T; Seki N
    J Hum Genet; 2018 May; 63(5):657-668. PubMed ID: 29540855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Focused screening reveals functional effects of microRNAs differentially expressed in colorectal cancer.
    Sastre D; Baiochi J; de Souza Lima IM; Canto de Souza F; Corveloni AC; Thomé CH; Faça VM; Schiavinato JLDS; Covas DT; Panepucci RA
    BMC Cancer; 2019 Dec; 19(1):1239. PubMed ID: 31864341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CircTADA2A suppresses the progression of colorectal cancer via miR-374a-3p/KLF14 axis.
    Li Z; Yao H; Wang S; Li G; Gu X
    J Exp Clin Cancer Res; 2020 Aug; 39(1):160. PubMed ID: 32799891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcription factor SP1-induced microRNA-146b-3p facilitates the progression and metastasis of colorectal cancer via regulating FAM107A.
    Wang D; Feng M; Ma X; Tao K; Wang G
    Life Sci; 2021 Jul; 277():119398. PubMed ID: 33831429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MTUS1 and its targeting miRNAs in colorectal carcinoma: significant associations.
    Ozcan O; Kara M; Yumrutas O; Bozgeyik E; Bozgeyik I; Celik OI
    Tumour Biol; 2016 May; 37(5):6637-45. PubMed ID: 26643896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiRNA-362-3p induces cell cycle arrest through targeting of E2F1, USF2 and PTPN1 and is associated with recurrence of colorectal cancer.
    Christensen LL; Tobiasen H; Holm A; Schepeler T; Ostenfeld MS; Thorsen K; Rasmussen MH; Birkenkamp-Demtroeder K; Sieber OM; Gibbs P; Lubinski J; Lamy P; ; Laurberg S; Oster B; Hansen KQ; Hagemann-Madsen R; Byskov K; Ørntoft TF; Andersen CL
    Int J Cancer; 2013 Jul; 133(1):67-78. PubMed ID: 23280316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-216a-3p inhibits colorectal cancer cell proliferation through direct targeting COX-2 and ALOX5.
    Wang D; Li Y; Zhang C; Li X; Yu J
    J Cell Biochem; 2018 Feb; 119(2):1755-1766. PubMed ID: 28786533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA TTN-AS1 sponges miR-376a-3p to promote colorectal cancer progression via upregulating KLF15.
    Wang Y; Jiang F; Xiong Y; Cheng X; Qiu Z; Song R
    Life Sci; 2020 Mar; 244():116936. PubMed ID: 31610194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNMT1 maintains the methylation of miR-152-3p to regulate TMSB10 expression, thereby affecting the biological characteristics of colorectal cancer cells.
    Wang C; Ma X; Zhang J; Jia X; Huang M
    IUBMB Life; 2020 Nov; 72(11):2432-2443. PubMed ID: 32918845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exosomal circPACRGL promotes progression of colorectal cancer via the miR-142-3p/miR-506-3p- TGF-β1 axis.
    Shang A; Gu C; Wang W; Wang X; Sun J; Zeng B; Chen C; Chang W; Ping Y; Ji P; Wu J; Quan W; Yao Y; Zhou Y; Sun Z; Li D
    Mol Cancer; 2020 Jul; 19(1):117. PubMed ID: 32713345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LINC02595 promotes tumor progression in colorectal cancer by inhibiting miR-203b-3p activity and facilitating BCL2L1 expression.
    Yang Z; An Y; Wang N; Dong X; Kang H
    J Cell Physiol; 2020 Oct; 235(10):7449-7464. PubMed ID: 32064615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.